Close Menu

NEW YORK (GenomeWeb) — Swedish liquid biopsy firm Saga Diagnostics said today that it has raised SEK 40 million ($4.2 million) in venture financing.

Hadean Ventures led the round with participation from existing investors including Fårö Capital and the Gunnar Nilsson Cancer Foundation.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.